ClinicalTrials.govpublic full text
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
myelodysplastic syndromes, cytopenia, transfusion, drug therapy, elritercept, tak-226, ker-050, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 903772
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.